Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C548651 |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in increased expression of BSN mRNA | increases expression | 19933214
|
C035207 |
4-amino-2,6-dinitrotoluene |
4-amino-2,6-dinitrotoluene affects the expression of BSN mRNA | affects expression | 21346803
|
C006780 |
bisphenol A |
bisphenol A results in decreased expression of BSN mRNA | decreases expression | 18180321
|
C014347 |
decitabine |
decitabine results in decreased expression of BSN mRNA | decreases expression | 19363521
|
C014347 |
decitabine |
TP53 protein affects the reaction [decitabine results in decreased expression of BSN mRNA] | affects reaction|decreases expression | 19363521
|
D004967 |
Estrogens |
Estrogens affects the expression of BSN mRNA | affects expression | 15473135
|
D004967 |
Estrogens |
Estrogens affects the expression of BSN mRNA | affects expression | 15473135
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of BSN mRNA | increases expression | 19933214
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
4-amino-2,6-dinitrotoluene |
10.07 | 7525203 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
10.07 | 14514962 15322242 11752688 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.84 | 16835633 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.25 | 11748828 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.37 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.31 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.95 | 15746008 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
4.19 | 11985600 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
1.90 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
decitabine |
1.90 | 18320071 19208741 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.90 | 20435547 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
3.05 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estrogens |
3.27 | 15341023 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
5.45 | 17123778 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
2.66 | 19215824 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.52 | 18850075 16120746 18670907 |
MESH:D002386 |
Cataract |
|
4-amino-2,6-dinitrotoluene |
3.79 | 14694615 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.45 | 16835633 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.21 | 8697196 15340226 15668235 12621046 16354765 |
MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
2.37 | 17616700 |
MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
2.10 | 18981723 |
MESH:D000013 |
Congenital Abnormalities |
|
4-amino-2,6-dinitrotoluene |
10.15 | 15095906 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
10.15 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.26 | 10048152 20055451 15322242 |
MESH:D016638 |
Critical Illness |
|
Estrogens |
6.41 | 16670151 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.72 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4-amino-2,6-dinitrotoluene |
4.19 | 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
4.19 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.99 | 11462148 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.70 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.42 | 16714409 15322242 18230668 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
5.64 | 19294695 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.33 | 9294722 10568697 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.24 | 11564622 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.87 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
3.36 | 20067830 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
5.12 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
3.69 | 19215824 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.47 | 10048152 11294989 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.66 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.31 | 16120746 12621046 15340226 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.57 | 16354765 18606429 8697196 15340226 16959395 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
2.00 | 18850075 18670907 |
MESH:D007248 |
Infertility, Male |
|
decitabine |
3.40 | 17581917 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
1.99 | 12878042 12200463 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
3.48 | 16393666 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.66 | 16580747 |
MESH:D007938 |
Leukemia |
|
decitabine |
3.21 | 19235587 18980019 |
MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
4.33 | 19117987 17236224 18454857 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
2.42 | 19387464 17679729 18206229 18704418 19010910 18460780 |
MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
5.98 | 18055864 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
1.25 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
1.81 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
2.28 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
1.24 | 19555203 11884234 |
MESH:D008223 |
Lymphoma |
|
decitabine |
3.64 | 19470736 |
MESH:D008545 |
Melanoma |
|
decitabine |
2.28 | 16505122 17785578 |
MESH:D009101 |
Multiple Myeloma |
|
decitabine |
3.56 | 18172295 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
3.54 | 18608210 19157545 16882708 19010910 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.27 | 12213967 |
MESH:D009369 |
Neoplasms |
|
decitabine |
2.84 | 19470736 19116145 17925555 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
10.88 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
10.88 | 14600291 |
MESH:D009784 |
Occupational Diseases |
|
4-amino-2,6-dinitrotoluene |
4.40 | 14694615 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
5.45 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
2.72 | 19331143 19259094 |
MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
2.85 | 19294695 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.77 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.94 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
11.10 | 10548101 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
11.10 | 11399792 11896295 11222880 11118676 |
MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
5.15 | 17616702 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
4.53 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
3.36 | 16740699 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
5.25 | 10548101 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.22 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
4.75 | 19155313 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
2.17 | 16192470 |
MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
2.10 | 19037991 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
4.45 | 16045194 16684133 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.42 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
3.57 | 17967635 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
2.82 | 19087683 17616700 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
5.53 | 14652134 |
MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
5.43 | 17785578 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
5.12 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.77 | 15886252 |
MESH:D014947 |
Wounds and Injuries |
|
Estrogens |
5.00 | 11172683 |